Beacon

📢 Exciting Announcement! We are thrilled to join the esteemed speaker faculty at the 15th Annual World Bispecific Summit in Boston. Our Lead Research Analyst, Flavio Lima Bianchi, will be presenting on "A Review of the Bispecific Landscape: The Past, The Present & The Future of Biologics." In this insightful session, we'll be: 🔬 Reviewing the current drug and trial landscape 📈 Discussing emerging trends in the bispecific landscape 💼 Outlining what the future holds for the bispecific space Get the full details about Flavio's opening presentation today - https://ter.li/ql8ezu We can’t wait to connect with industry leaders and contribute to the conversation! See you there! #worldbispecific #antibody #antibodydiscovery #antibodytherapeutics #antibodyenginnering #bispecific #bispecificantibody

📣 Dive Deeper into STING & TLR Innovations! 🚀 Missed our recent webinar, "Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape"? Don't worry, you can still catch up! Watch the session on demand to explore the latest advancements in the STING & TLR pipeline, discover new combination therapies, and dive into innovative strategies shaping the future of treatment. 🔗 Watch Now: https://ter.li/z3x8at Stay informed and ahead in the dynamic field of STING & TLR-targeted therapies! #ImmunoOncology #STING #TLR #Checkpoint

Missed our live webinar on the latest in Inflammatory Bowel Disease (IBD) treatments? No worries! You can now watch it on demand. Catch up on all the insights into key drug modalities, recent approvals, market growth drivers, and more at your convenience. 🎥 Watch Now: https://ter.li/1rh5bs Stay informed and explore the cutting-edge developments driving the IBD market from Beacon Immune Tolerance and Hanson Wade Intelligence! #InflammatoryBowelDisease #IBD #JAKinhibitors #TNFalphas #S1Preceptors #DrugTrends #MarketAnalysis

🔬 Thrilled to be part of the Microbiome Movement Drug Development Summit in Boston once again this year! And a special shoutout to our Microbiome Research Analyst, Ada Lam, for her stellar presentation. Offering a comprehensive analysis of the US and Asian markets and an in-depth examination of LBP development, Ada took a deep dive into how the microbiome space is demonstrating significant resilience and growth! To get a glimpse of the latest data delivered, contact our team Rais Malik or Callum Sleath directly, or get in touch at beacon@hansonwade.com. #MicrobiomeMovement #DrugDevelopment #BiotechInnovation

🔥 Exciting News! Missed our recent STING & TLR webinar? We've got you covered! You can now watch "Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape" on demand! 🧬 Catch up on the latest advancements in the STING & TLR pipeline, discover promising combination therapies, and explore innovative strategies driving this field at your convenience. 🔗 Watch On Demand: https://ter.li/z3x8at Don't miss out on staying at the forefront of STING & TLR-targeted treatment innovations! #ImmunoOncology #STING #TLR #Checkpoint

Discover the latest trends in early-stage biopharma investments with our comprehensive report, "Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective." From Series A financing peaks to the dominance of biologicals and the resurgence of biopharma IPOs, get all the insights you need to stay ahead in the market. 📥 Download your free copy today! 👉 https://ter.li/wtpcs3 #Biopharma #InvestmentTrends #SeriesAFinancing #BeaconData #MarketInsights #InvestmentStrategy

Didn't catch our webinar on IBD treatments and market trends? Great news! It’s still available on demand. Dive into key insights on the latest drug modalities, market drivers, and recent approvals whenever it suits you. 🎥 Watch Now: https://ter.li/1rh5bs **WATCH ANYTIME** and keep yourself informed with Beacon Immune Tolerance and Hanson Wade Intelligence! #InflammatoryBowelDisease #IBD #JAKinhibitors #TNFalphas #S1Preceptors #DrugTrends #MarketAnalysis

Our highly anticipated cell therapy webinar is just one week away, so secure your spot before it's too late ⏳ https://ter.li/9bwzoc Get ready to explore how allogeneic cell therapies are making waves with scalable and innovative alternatives to traditional autologous treatments. Here’s a sneak peek: 💸 Total deal value involving allogeneic cell therapies in 2023 was $981 million, but this year we’ve already surpassed that investment! 🔬 130 allogeneic trials have their end dates this year, providing a wealth of new data and insights. 🧪 Over 440 allogeneic trials are currently recruiting participants. Find out more about these promising developments. Our expert panel will dive deep into these exciting advancements. Don’t miss the chance to stay ahead of the curve and unlock the potential of cutting-edge allogeneic solutions in oncology and beyond. #CellTherapy #Allogeneic #AllogeneicTherapies #MarketInsights Hanson Wade Intelligence

📢 Exciting Announcement: Feel the buzz surrounding the latest advancements in cell therapy in our upcoming webinar! Discover how allogeneic cell therapies are revolutionizing the field with scalable and innovative alternatives to traditional autologous treatments. Join our expert panel for an exclusive deep dive into these exciting advancements. Register Now 🔗 https://ter.li/9bwzoc Don't miss out on insights, from Beacon's Rachel East and Hanson Wade Intelligence’s Ahmed Tajmohamed, that could shape your strategic decisions in the evolving cell therapy landscape. Unlock the potential of cutting-edge allogeneic solutions in oncology and beyond. #CellTherapy #Allogeneic #AllogeneicTherapies #MarketInsights

All eyes were on Ioana Panait at Oligonucleotides for CNS this week. Another insightful talk from our Beacon RNA Senior Research Analyst, covering the scientific and commercial landscape with expert knowledge and insight into current and upcoming trends, using both the data and her expertise! If you would like to get a glimpse of the stellar presentation delivered, contact our team Matty Slingsby or Jake Morris directly, or get in touch at beacon@hansonwade.com. #RNA #oligonucleotidesforCNS #oligonucleotides